Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bates

Showing results (1101-1110 of 1,204) with videos related to

Pageof 121
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2010
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancerRonan J Kelly, Deborah Draper, Clara C Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
The role of breast cancer resistance protein in acute lymphoblastic leukemiaSabine L A Plasschaert, Dorina M van der Kolk, Eveline S J M de Bont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2019
Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor StudyJames E Bates, Rebecca M Howell, Qi Liu, et al.
Pediatrics|September 22, 2023
Ensuring No Death Is Ignored: Development of a Hospital Mortality Review and Notification SystemKatherine E Bates, Bethany Freeland, Kathryn L Levy, et al.
Anti-Cancer Drugs|February 9, 2018
Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lungSanjeeve Balasubramaniam, Christophe E Redon, Cody J Peer, et al.
The International Journal of Biochemistry & Cell Biology|April 15, 2014
Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10-mediated drug resistanceHui Zhang, Rishil J Kathawala, Yi-Jun Wang, et al.
Journal of the American Academy of Dermatology|August 25, 2024
Keratinocyte carcinomas in survivors of childhood cancer: A report from the childhood cancer survivor studyChristina Boull, Yan Chen, Cindy Im, et al.
The Oncologist|March 18, 2026
Phase 2 Study of Azacitidine plus Pembrolizumab as Second-Line Treatment in Patients with Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaRachael A Safyan, Ruth A White, Tamas A Gonda, et al.
Advances in Radiation Oncology|January 3, 2022
Demographics of ASTRO Student Members and Potential Implications for Future U.S. Radiation Oncology Workforce DiversityMalcolm D Mattes, Curtiland Deville, Raymond B Mailhot Vega, et al.
Cardiology in the Young|June 25, 2025
Sustaining and spreading success: expanding a multicentre quality improvement project to reduce postoperative chest tube duration after paediatric CHDShreya S Sheth, Ashlin Tignor, Chloe Connelly, et al.
Pageof 121

Showing results (1101-1110 of 1,204) with videos related to

Sort By:
Pageof 121
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2010
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancerRonan J Kelly, Deborah Draper, Clara C Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
The role of breast cancer resistance protein in acute lymphoblastic leukemiaSabine L A Plasschaert, Dorina M van der Kolk, Eveline S J M de Bont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2019
Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor StudyJames E Bates, Rebecca M Howell, Qi Liu, et al.
Pediatrics|September 22, 2023
Ensuring No Death Is Ignored: Development of a Hospital Mortality Review and Notification SystemKatherine E Bates, Bethany Freeland, Kathryn L Levy, et al.
Anti-Cancer Drugs|February 9, 2018
Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lungSanjeeve Balasubramaniam, Christophe E Redon, Cody J Peer, et al.
The International Journal of Biochemistry & Cell Biology|April 15, 2014
Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10-mediated drug resistanceHui Zhang, Rishil J Kathawala, Yi-Jun Wang, et al.
Journal of the American Academy of Dermatology|August 25, 2024
Keratinocyte carcinomas in survivors of childhood cancer: A report from the childhood cancer survivor studyChristina Boull, Yan Chen, Cindy Im, et al.
The Oncologist|March 18, 2026
Phase 2 Study of Azacitidine plus Pembrolizumab as Second-Line Treatment in Patients with Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaRachael A Safyan, Ruth A White, Tamas A Gonda, et al.
Advances in Radiation Oncology|January 3, 2022
Demographics of ASTRO Student Members and Potential Implications for Future U.S. Radiation Oncology Workforce DiversityMalcolm D Mattes, Curtiland Deville, Raymond B Mailhot Vega, et al.
Cardiology in the Young|June 25, 2025
Sustaining and spreading success: expanding a multicentre quality improvement project to reduce postoperative chest tube duration after paediatric CHDShreya S Sheth, Ashlin Tignor, Chloe Connelly, et al.
Pageof 121